SU-GG-T-106: Simultaneous Integrated Boost Radiotherapy Using Volumetric Modulated Arc Therapy (RapidArc) in the Treatment of Head&Neck Cancer: A Dosi metric Comparison with Helical TomoTherapy and Intensity Modulated Radiotherapy

2010 ◽  
Vol 37 (6Part17) ◽  
pp. 3208-3208
Author(s):  
M Yeginer ◽  
B Aydogan ◽  
B Smith ◽  
J Turian ◽  
G Kim
Keyword(s):  
Neck Cancer ◽  
Helical Tomotherapy ◽  
Volumetric Modulated Arc Therapy ◽  
Intensity Modulated Radiotherapy ◽  
Head Neck Cancer ◽  
Intensity Modulated ◽  
Arc Therapy ◽  
Integrated Boost ◽  
Boost Radiotherapy ◽  
Head Neck

Which simultaneous-integrated boost (SIB) intensity-modulated radiotherapy (IMRT) technique is dosimetrically superior in the treatment of breast cancer; volumetric-modulated arc therapy (VMAT) or fixed field (ff) IMRT?

2017 ◽  
Vol 16 (3) ◽  
pp. 272-279
Author(s):  
Steven B. D. Murphy ◽  
Heather Drury-Smith
Keyword(s):  
Breast Cancer ◽  
Volumetric Modulated Arc Therapy ◽  
Intensity Modulated Radiotherapy ◽  
Breath Hold ◽  
Hybrid Technique ◽  
Fixed Field ◽  
Intensity Modulated ◽  
Concomitant Boost ◽  
Arc Therapy ◽  
Integrated Boost

AbstractBackground and purposeTo determine which concomitant boost technique is dosimetrically superior in the treatment of breast cancer; volumetric-modulated arc therapy (VMAT) or fixed field intensity-modulated radiotherapy (ff-IMRT).Materials and methodsIn total, 30 breast patients were re-planned with both VMAT and fixed field concomitant boost intensity-modulated radiotherapy techniques. A hybrid technique was used delivering 80% of the dose through tangential beams and 20% through an integrated boost. A two-tailed t-test sample for means was used to compare the dosimetric differences between the techniques.ResultsMaximum dose was statistically lower for VMAT; 103·2 versus 103·7% for ff-IMRT along with statistically lower V2 Gy doses to the contralateral lung (0·7 versus 1·6%) and heart for both left- (19·0%/22·6%), and right- (5·5%/8·8%) sided patients, respectively. ff-IMRT boasted significantly lower ipsilateral lung V20, V18 and V10 Gy (7·9/8·6/13·1 versus 8·1/8·8/13·4%) than VMAT, respectively. No differences were found with minimum coverage, mean dose and V5 Gy to all organs at risk (OARs).ConclusionVMAT and ff-IMRT techniques demonstrate excellent target coverage and OAR sparing facilitated by the hybrid planning technique and deep inspiration breath hold. There is no obvious dosimetrically superior option between the two techniques. Reduced treatment times with VMAT make it more desirable to implement clinically.

Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry

Head & Neck ◽  
2016 ◽  
Vol 38 (7) ◽  
pp. 1028-1034 ◽  
Author(s):  
Alexis Vallard ◽  
Jean-Baptiste Guy ◽  
Sylvie Mengue Ndong ◽  
Nicolas Vial ◽  
Romain Rivoirard ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Salivary Glands ◽  
Neck Cancer ◽  
Volumetric Modulated Arc Therapy ◽  
Intensity Modulated Radiotherapy ◽  
Intensity Modulated ◽  
Arc Therapy

TU-D-AUD B-01: Volumetric Modulated Arc Therapy for Head & Neck Cancer

2008 ◽  
Vol 35 (6Part21) ◽  
pp. 2901-2901
Author(s):  
MKN Afghan ◽  
D Cao ◽  
V Mehta ◽  
D Shepard
Keyword(s):  
Neck Cancer ◽  
Volumetric Modulated Arc Therapy ◽  
Head Neck Cancer ◽  
Arc Therapy ◽  
Head Neck

Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in hippocampus sparing in brain metastasis treated by whole-brain irradiation and simultaneous integrated boost

2019 ◽  
Vol 19 (1) ◽  
pp. 45-51 ◽  
Author(s):  
Ehab Saad ◽  
Khaled Elshahat ◽  
Hussein Metwally
Keyword(s):  
Brain Metastasis ◽  
Organs At Risk ◽  
Volumetric Modulated Arc Therapy ◽  
Intensity Modulated Radiotherapy ◽  
Simultaneous Integrated Boost ◽  
Conformity Index ◽  
Whole Brain ◽  
Intensity Modulated ◽  
Arc Therapy ◽  
Integrated Boost

AbstractBackground:While treating brain metastasis with whole-brain radiotherapy incorporating a simultaneous integrated boost (WBRT-SIB), the risk of hippocampus injury is high. The aim of this study is to compare dosimetrically between intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in sparing of hippocampus and organs at risk (OARs) and planning target volume (PTV) coverage.Methods:In total, 16 patients presenting with more than one brain metastases were previously treated and then retrospectively planned using VMAT and IMRT techniques. For each patient, a dual-arc VMAT and another IMRT (five beams) plans were created. For both techniques, 30 Gy in 10 fractions was prescribed to the whole brain (WB) minus the hippocampi and 45 Gy in 10 fractions to the tumour with 0·5 cm margin. Dose–volume histogram (DVH), conformity index (CI) and homogeneity index (HI) of PTV, hippocampus mean and maximum dose and other OARs for both techniques were calculated and compared.Results:A statistically significant advantage was found in WB-PTV CI and HI with VMAT, compared to IMRT. There were lower hippocampus mean and maximum doses in VMAT than IMRT. The maximum hippocampus dose ranged between 15·5 and 19·2 Gy and between 18·4 and 20·6 Gy in VMAT and IMRT, respectively. The mean dose of the hippocampus ranged between 11·5 and 17·7 Gy and between 13·2 and 18·3 Gy in VMAT and IMRT, respectively.Conclusion:Using WBRT-SIB technique, VMAT showed better PTV coverage with less mean and maximum doses to the hippocampus than IMRT. Clinical randomised studies are needed to confirm safety and clinical benefit of WBRT-SIB.

Sign in / Sign up

Export Citation Format

Share Document